Cargando…

SGLT2 inhibition reduces myocardial oxygen consumption

AIMS/HYPOTHESIS: SGLT2 inhibition is associated with a reduced risk of cardiac disease that is still largely unexplained. According to one hypothesis, improved myocardial energetics may explain the cardioprotective effects of SGLT2i. However, recent mechanistic studies that have addressed this quest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Søndergaard, Esben, Lauritzen, Esben S., Lauritsen, Katrine M., Åkerblom, Axel, Nuutila, Pirjo, Oldgren, Jonas, Gormsen, Lars C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460164/ https://www.ncbi.nlm.nih.gov/pubmed/36092797 http://dx.doi.org/10.1016/j.metop.2022.100207

Ejemplares similares

Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetes
por: Lauritsen, Katrine M, et al.
Publicado: (2022)

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study
por: Åkerblom, Axel, et al.
Publicado: (2019)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Ketogenic Diet and Cardiac Substrate Metabolism
por: Luong, Thien Vinh, et al.
Publicado: (2022)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Ketone Body Infusion With 3‐Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study
por: Gormsen, Lars C., et al.
Publicado: (2017)

Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women
por: Søndergaard, Esben, et al.
Publicado: (2011)

Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-(11)C]β-hydroxybutyrate ([(11)C]OHB) PET in healthy humans
por: Luong, Thien Vinh, et al.
Publicado: (2023)

Ex Vivo Human Placenta Perfusion, Metabolic and Functional Imaging for Obstetric Research—A Feasibility Study
por: Elbæk Madsen, Katrine, et al.
Publicado: (2019)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
por: Pitt, Bertram, et al.
Publicado: (2021)

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients
por: Christersson, Christina, et al.
Publicado: (2017)

Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors
por: Qiu, Mei, et al.
Publicado: (2021)

Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
por: Clemmensen, Tor Skibsted, et al.
Publicado: (2018)

Development of the annual incidence rate of fracture in children 1980–2018: a population-based study of 32,375 fractures
por: Larsen, Andreas V, et al.
Publicado: (2020)

Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial
por: Svart, Mads, et al.
Publicado: (2018)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

Oxygen Consumption Deficits in Patients With Residual Fatigue After Primary Coccidioidomycosis
por: Ganley, Kathleen J, et al.
Publicado: (2017)

Inverse Cutting of Posterior Lamellar Corneal Grafts by a Femtosecond Laser
por: Hjortdal, Jesper, et al.
Publicado: (2012)

Ghrelin Infusion in Humans Induces Acute Insulin Resistance and Lipolysis Independent of Growth Hormone Signaling
por: Vestergaard, Esben Thyssen, et al.
Publicado: (2008)

LPS infusion suppresses serum FGF21 levels in healthy adult volunteers
por: Lauritzen, Esben S, et al.
Publicado: (2017)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes—A randomized placebo‐controlled crossover trial
por: Lauritzen, Esben S., et al.
Publicado: (2022)

Comparable Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Basal Fuel Metabolism and Insulin Sensitivity in Individuals with Obesity and Type 2 Diabetes
por: Brodersen, Katrine, et al.
Publicado: (2022)

Renal Perfusion, Oxygenation and Metabolism: The Role of Imaging
por: Päivärinta, Johanna, et al.
Publicado: (2023)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Batra, Gorav, et al.
Publicado: (2017)

GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression
por: Qiu, Mei, et al.
Publicado: (2020)

Complications in Patients with Acute Myocardial Infarction Supported with Extracorporeal Membrane Oxygenation
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2020)

Exchange of oxygen across the epicardial surface distorts estimates of myocardial oxygen consumption
Publicado: (1989)

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study
por: Kosiborod, Mikhail, et al.
Publicado: (2018)

Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus
por: Sørensen, Lars Peter, et al.
Publicado: (2015)

Low Walking Impairment Questionnaire score after a recent myocardial infarction identifies patients with polyvascular disease
por: Jönelid, Birgitta, et al.
Publicado: (2019)

Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis
por: Stougaard, Elisabeth B, et al.
Publicado: (2022)

Feeding and growth of the marine heterotrophic nanoflagellates, Procryptobia sorokini and Paraphysomonas imperforata on a bacterium, Pseudoalteromonas sp. with an inducible defence against grazing
por: Tophøj, Jakob, et al.
Publicado: (2018)

Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin
por: Ouchi, Motoshi, et al.
Publicado: (2018)

Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure
por: Hansson, Nils Henrik Stubkjær, et al.
Publicado: (2017)

Registry-Based Pragmatic Trials in Heart Failure: Current Experience and Future Directions
por: Lund, Lars H., et al.
Publicado: (2017)

SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review
por: Janež, Andrej, et al.
Publicado: (2021)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022)

Copeptin levels increase in response to both insulin-induced hypoglycemia and arginine but not to clonidine: data from GH-stimulation tests
por: Stankovic, Jelena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d5m6tujudkh55gdvqrjter79g3